Prabhakar, S., Cheah, P. S., Zhang, X., Zinter, M., Gianatasio, M., Hudry, E., . . . Breakefield, X. O. (2019). Long-term therapeutic efficacy of intravenous AAV-mediated hamartin replacement in mouse model of tuberous sclerosis type 1. Cell Press.
Chicago Style (17th ed.) CitationPrabhakar, Shilpa, et al. Long-term Therapeutic Efficacy of Intravenous AAV-mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1. Cell Press, 2019.
MLA (9th ed.) CitationPrabhakar, Shilpa, et al. Long-term Therapeutic Efficacy of Intravenous AAV-mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1. Cell Press, 2019.
Warning: These citations may not always be 100% accurate.